http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2769989-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_444a4400392d34e80d06c30c09a7e0fb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f9304db26d485f2931a74249e23fef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809565bffb7665a40b7b96ead2e69af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c138d3d18a1b594b250aa60578855590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84eb2abfb8e6a55cd3b6a5ad06a0bc18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ad6278f7177e6c1b3c63d518e931ff
publicationDate 2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2769989-A1
titleOfInvention Recombinant bispecific antibody that binds to the CD133 antigen on tumor cells and to the human CD3 T cell receptor
abstract The present invention relates to recombinant bispecific antibodies that bind specifically to the CD133 surface antigen, which is expressed on tumor cells and that bind also to T cells via the CD3 receptor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11220551-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11214628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3529279-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10106623-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110352198-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3916018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11007267-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015121383-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016204966-A1
priorityDate 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010119119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010209439-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54677470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128353489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13649426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226560155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53436351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420042

Total number of triples: 45.